The Anatomy of Addiction (20 page)

Aalto, M., Pekuri, P., & Seppa, K. (2003). “Obstacles to carrying out brief intervention for heavy drinkers in primary health care: A focus group study.”
Drug and Alcohol Review
22 (2): 169–73.

Abbott, P. J., Quinn, D., & Knox, L. (1995). “Ambulatory medical detoxification for alcohol.”
American Journal of Drug & Alcohol Abuse
21 (4): 549–63.

Abraham, A. J., & Roman, P. M. (2010). “Early adoption of injectable naltrexone for alcohol-use disorders: Findings in the private-treatment sector.”
Journal of Studies on Alcohol and Drugs
71 (3): 460–66.

Abraham, A. J., Knudsen, H. K., & Roman, P. M. (2011). “A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: Patterns of sustainability and discontinuation.”
Journal of Studies on Alcohol and Drugs
72 (4): 669–77.

Adams, J. B., Heath, A. J., Young, S. E., Hewitt, J. K., Corley, R. P., & Stallings, M. C. (2003). “Relationships between personality and preferred substance and motivations for use among adolescent substance abusers.”
American Journal of Drug and Alcohol Abuse
29 (3): 691–712.

Agrawal, A., & Lynskey, M. T. (2008). “Are there genetic influences on addiction: Evidence from family, adoption and twin studies.”
Addiction
103 (7): 1069–81.

Alcoholics Anonymous World Services. (1972).
A Brief Guide to Alcoholics Anonymous
.

Alexander, J. A., Nahra, T. A., Lemak, C. H., Pollack, H., & Campbell, C. I. (2008). “Tailored treatment in the outpatient substance abuse treatment sector: 1995–2005.”
Journal of Substance Abuse Treatment
34 (3): 282–92.

Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). “An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research.”
Journal of Substance Abuse
28 (4): 321–29.

American Board of Addiction Medicine Foundation. (2009).
The Need for Addiction Medicine Physicians and for Addiction Medicine Residency Training Programs: A Report of the American Board of Addiction Medicine Foundation
. Chevy Chase, MD.

American Medical Association. (2011). H-95.976. “Drug abuse in the United States: The next generation.” Available at ssl3.ama-assn.org.

American Medical Association, Council on Scientific Affairs. (1979).
Guidelines for Alcoholism Diagnosis: Treatment and Referral
. Chicago.

American Psychiatric Association. (2008). “Substance use disorders: Physician performance measurement set: PCPI approved.” Available at www.ama-assn.org.

American Society of Addiction Medicine. (2011). “Definition of addiction: Frequently asked questions.” Available at www.asam.org.

Anderson, A. L., Reid, M. S., Li, S. H., et al. (2009). “Modafinil for the treatment of cocaine dependence.”
Drug and Alcohol Dependence
104 (1–2): 133–39.

Anonymous. (2012, February 22). “A rewired brain: Many now see addiction as a chronic brain disease that requires new approaches to treatment.”
Wall Street Journal
. Available at http://online.wsj.com/ad/cigna/cigna_article.htm.

Anthony, E. K., Taylor, S. A., & Raffo, Z. (2011). “Early intervention for substance abuse among youth and young adults with mental health conditions: An exploration of community mental health practices.”
Administration and Policy in Mental Health
38 (3): 131–41.

Anton, R. F., Moak, D. H., Latham, P., et al. (2005). “Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.”
Journal of Clinical Psychopharmacology
25 (4): 349–57.

Anton, R. F., & Swift, R. M. (2003). “Current pharmacotherapies of alcoholism: A U.S. perspective.”
American Journal on Addictions
12 (1): S53–S68.

Appel, P. W., Ellison, A. A., Jansky, H. K., & Oldak, R. (2004). “Barriers to enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders.”
American Journal of Drug and Alcohol Abuse
30 (1): 129–53.

Arias, A. J., & Kranzler, H. R. (2008). “Treatment of co-occurring alcohol and other drug use disorders.”
Alcohol Research and Health
31 (2): 155–67.

Atkinson, R. M., Ganzini, L., & Bernstein, M. J. (1992). “Alcohol and substance-use disorders in the elderly.” In J. E. Birren, R. B. Sloane, & G. D. Cohen, eds.,
Handbook of Mental Health and Aging
(pp. 516–55). New York: Academic Press.

Azrin, N. H., Sisson, W., Myers, R., & Godley, M. (1982). “Alcoholism treatment by disulfiram and community reinforcement therapy.”
Journal of Behavior Therapy and Experimental Psychiatry
13 (2): 105–12.

Babor, T. F., & Hall, W. (2007). “Editorial: Standardizing terminology in addiction science: To achieve the impossible dream.”
Addiction
102 (7): 1015–18.

Babor, T. F., & Kadden, R. M. (2005). “Screening and interventions for alcohol and drug problems in medical settings: What works?”
Journal of Trauma
59 (Suppl. 3): S80–S87.

Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004). “Cognitive effects of long-term benzodiazepine use. A meta-analysis.”
CNS Drugs
18 (1): 37–48.

Barnett, P. G., Zaric, G. S., & Brandeau, M. L. (2001). “The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States.”
Addiction
96 (9): 1267–278.

Bava, S., Frank, L. R., McQueeny, T., Schweinsburg, B. C., Schweinsburg, A. D., & Tapert, S. F. (2009). “Altered white matter microstructure in adolescent substance users.”
Psychiatry Research
173 (3): 228–37.

Bazelon Center for Mental Health Law. (2010). “Medicaid reforms in the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act.” Available at www.bazelon.org.

Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006). “A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.”
Archives of General Psychiatry
63 (4): 426–32.

Biery, J. R., Williford, J. H., Jr., & McMullen, E. A. (1991). “Alcohol craving in rehabilitation: Assessment of nutrition therapy.”
Journal of the American Dietetic Association
91 (4): 463–66.

Bina, R., Yum, J., Hall, D., Sowbel, L., et al. (2008). “Substance abuse training and perceived knowledge: Predictors of perceived preparedness to work in substance abuse.”
Journal of Social Work Education
44 (3): 7–20.

Bishop, E. S. (1919). “Narcotic drug addiction: A public health problem.”
American Journal of Public Health
9 (7): 481–88.

Block, M. A. (1956). “Medical treatment of alcoholism.”
JAMA
162 (18): 1610–619.

Boden, M. T., Kimerling, R., Jacobs-Lentz, J., et al. (2011). “Seeking safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomology.”
Addiction
107 (3): 578–86.

Boden, M. T., & Moos, R. (2009). “Dually diagnosed patients' responses to substance use disorder treatment.”
Journal of Substance Abuse Treatment
37 (4): 335–45.

Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002). “Improving primary care for patients with chronic illness: The chronic care model, Part 2.”
JAMA
288 (15): 1909–914.

Bollerud, K. (1990). “A model for the treatment of trauma-related syndromes among chemically dependent inpatient women.”
Journal of Substance Abuse Treatment
7 (2): 83–87.

Bonnie, R. J., & O'Connell, M. E. (2004).
Reducing underage drinking: A collective responsibility
. Washington, D.C.: National Academies Press.

Boothby, L. A., & Doering, P. L. (2007). “Buprenorphine for the treatment of opioid dependence.”
American Journal of Health-System Pharmacy
64 (3): 266–72.

Bowen, O. R., & Sammons, J. H. (1988). “The alcohol-abusing patient: A challenge to the profession.”
JAMA
260 (15): 2267–270.

Brady, J. P., Posner, M., Lang, C., & Rosati, M. J. (1994).
Risk and reality: The implications of prenatal exposure to alcohol and other drugs
. Rockville, MD: U.S. Department of Health and Human Services and the U. S. Department of Education, Educational Development Center.

Brown, B. S., & Flynn, P. M. (2002). “The federal role in drug abuse technology transfer: A history and perspective.”
Journal of Substance Abuse Treatment
22 (4): 245–57.

Brown, J. D., Vartivarian, S., & Alderks, C. E. (2011). “Child care in outpatient substance abuse treatment facilities for women: Findings from the 2008 National Survey of Substance Abuse Treatment Services.”
Journal of Behavioral Health Services & Research
38 (4): 478–87.

Brown, R. L., Leonard, T., Saunders, L. A., & Papasouliotis, O. (1998). “The prevalence and detection of substance use disorders among inpatients ages 18 to 49: An opportunity for prevention.”
Preventive Medicine
27 (1): 101–10.

Buck, J. A. (2011). “The looming expansion and transformation of public substance abuse treatment under the affordable care act.”
Health Affairs
30 (8): 1402–410.

Buddy, T. (2010). “Naltrexone—Treatment for alcoholism and addiction: Blocks effects of opioids, reduces alcohol craving.” Available at alcoholism.about.com.

Buddy, T. (2007). “New vaccines help stop drug addiction?” Available at alcoholism.about.com.

Burge, S. K., & Schneider, F. D. (1999). “Alcohol-related problems: Recognition and intervention.”
American Family Physician
59 (2): 361–70, 372.

Burke, B. L., Arkowitz, H., & Menchola, M. (2003). “The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials.”
Journal of Consulting and Clinical Psychology
71 (5): 843–61.

Burrow-Sanchez, J., Call, M. E., Adolphson, S. L., & Hawken, L. S. (2009). “School psychologists' perceived competence and training needs for student substance abuse.”
Journal of School Health.

Burrow-Sanchez, J. J., & Lopez, A. L. (2009). “Identifying substance abuse issues in high schools: A national survey of high school counselors.”
Journal of Counseling and Development
87 (1): 72–79.

Burton, L. M. (1992). “Black grandparents rearing children of drug-addicted parents: Stressors, outcomes, and social service needs.”
Gerontologist
32 (6): 744–51.

Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986). “Withdrawal reaction after long-term therapeutic use of benzodiazepines.”
New England Journal of Medicine
315 (14): 854–59.

Calhoun, P. S., Elter, J. R., Jones, E. R. Jr., Kudler, H., & Straits-Troster, K. (2008). “Hazardous alcohol use and receipt of risk-reduction counseling among U.S. veterans of the wars in Iraq and Afghanistan.”
Journal of Clinical Psychiatry
69 (11): 1686–693.

Califano, J. A. (2007).
High society: How substance abuse ravages America and what to do about it
. New York: Public Affairs.

California Board of Behavioral Sciences. (2012). “Continuing education (CE) provider application.” Available at www.bbs.ca.gov.

Callahan, D. (1999). “Remembering the goals of medicine.”
Journal of Evaluation in Clinical Practice
5 (2): 103–106.

Carey, K. B. (2008, December 22). “Drug rehabilitation or revolving door?”
New York Times
, p. 1D.

Carey, K. B., Bradizza, C. M., Stasiewicz, P. R., & Maisto, S. A. (1999). “The case for enhanced addictions training in graduate programs.”
Behavior Therapist
22 (2): 27–31.

Carroll, K. M. (1996). “Relapse prevention as a psychosocial treatment: A review of controlled clinical trials.”
Experimental and Clinical Psychopharmacology
4 (1): 46–54.

Carroll, K. M., Ball, S. A., Nich, C., et al. (2001). “Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: Efficacy of contingency management and significant other involvement.”
Archives of General Psychiatry
58 (8): 755–61.

Carroll, K. M., Fenton, L., Ball, R. (2004). “Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial.”
Archives of General Psychiatry
61 (3): 264–72.

Carroll, K. M., Rounsaville, B. J., Nich, C., Gordon, L., & Gawin, F. (1995). “Integrating psychotherapy and pharmacotherapy for cocaine dependence: Results from a randomized clinical trial.”
NIDA Research Monograph
150: 19–35.

CASAColumbia (2012). “Addiction medicine: Closing the gap between science and practice. Results from a 5-year study.” Available at http://www.casacolumbia.org/addiction-research/reports/addiction-medicine.

Cassel, E. J. (1982). “The nature of suffering and the goals of medicine.”
New England Journal of Medicine
306 (11): 639–45.

Catholic University of America. (2010). “Summary of federal laws.
The Controlled Substances Act of 1970 (Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970).” Available at counsel.cua.edu.

Center for Substance Abuse Treatment. (2011). “About buprenorphine therapy.” Available at buprenorphine.samhsa.gov.

Center for Substance Abuse Treatment. (2005). “Acamprosate: A new medication for alcohol use disorders (DHHS Pub. No. (SMA) 05-4114).”
Substance Abuse Treatment Advisory
4 (1).

Center for Substance Abuse Treatment. (2012). “Buprenorphine information center.” Available at buprenorphine.samhsa.gov.